Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
FOXO4-DRI and endothelial-cell senescence
2026 endothelial and mouse-aging-model study; PMID 41625068.
Epitalon and telomere length in human cell lines
Cell study. 2025. PMID 40908429.
PNC-27 experimental antitumor study
Preclinical study. 2025. PMID 40750238.
FDA Drug Trials Snapshot: Forzinity
U.S. FDA. Approval date September 19, 2025; SPIBA-201 population and endpoint record.
TESTS phase 3 thymosin alpha-1 sepsis trial
Primary 2025 multicenter trial; PMID 39814420.
PNC-27 membrane-associated anticancer research
Preclinical study. 2024. PMID 38802154.
Thymalin in rat mandibular regeneration
Preclinical study. 2024. PMID 38642352.
Epitalon delays postovulatory aging of mouse oocytes
Preclinical study. 2022. PMID 35413689.
Nicotinamide adenine dinucleotide in cardiac remodeling and aging
Mini-review. 2022. PMID 35249481.
Elamipretide phase 2/3 trial in Barth syndrome
Reid Thompson W, et al. Genetics in Medicine. 2021. PMID 33077895.
FOXO4-DRI and age-related Leydig-cell dysfunction
Preclinical study. 2020. PMID 31959736.
Thymalin and human hematopoietic stem cells
Cell study. 2020. PMID 33237528.
Thymosin alpha 1: a comprehensive review of the literature
Dominari A, et al. World J Virol. 2020. PMID 33362999.
Thymosin alpha 1 treatment for patients with sepsis
Clinical review. 2018. PMID 30063866.
Targeted apoptosis of senescent cells restores tissue homeostasis
Baar MP, et al. Cell. 2017. PMID 28340339.
Pinealon in a prenatal hyperhomocysteinemia model
Preclinical study. 2012. PMID 22567179.
Pinealon effects on cell viability and proliferative processes
Cell study. 2011. PMID 21978084.
NAD+ metabolism and the control of energy homeostasis
Houtkooper RH, et al. Endocr Rev. 2010. PMID 19149596.
Care and handling of peptides
Care and handling of peptides
Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides.
SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides.
Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis
Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis
Research news reference — onlinelibrary.wiley.com — news-17
Research news reference — pubmed.ncbi.nlm.nih.gov — news-16
Research news reference — pubmed.ncbi.nlm.nih.gov — news-10
Primary publication — PubMed 25117093
Primary publication — PubMed 23692570
Primary publication — PubMed 30597195
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
